Boston Aesthetics is a global medical aesthetics technology
company defined by clinical needs, realized through engineering, validated by science,
and driven by accessibility.
Scroll
Who we are
Founded to challenge the status quo.
Boston Aesthetics was founded in Boston in 2024 and established its global headquarters in
Irvine, California in 2025. Rooted in the United States and driven by global vision, we are a
pioneering medical aesthetics technology company.
Over the past several decades, industry pioneers laid the foundation for modern energy-based
aesthetics. Yet the structural compromises of clinical and commercial practice remain:
The Patient Equation
Clinical Efficacy
vs.
Severe Discomfort
The Physician Equation
Cutting-edge Technology
vs.
Capital Costs
The Operations Equation
Short-term Profits
vs.
Long-term Gains via Growth and Partnerships
We believe these frictions are not inevitable trade-offs. We were founded to challenge the
status quo: to continually improve treatment comfort, to make advanced medical technology more
accessible, and to build a sustainable ecosystem in the industry.
Our mission: To bring cutting-edge medical technology within reach.
Beauty with No Boundary.
How we work
Three commitments that shape every device we build.
01
Clinically Defined
We innovate from the bedside out. Every product starts with a real clinical challenge —
not a technology looking for a market.
02
Engineering-Driven
We turn “what if” into “how.” Complex science becomes a device that is intuitive in the
hand and predictable in outcome.
03
Scientifically Validated
Every solution we bring to market is backed by clinical evidence and peer-reviewed
research.
Global by design
Built to be global from day one.
Global headquartersIrvine, CaliforniaRegional networksAPAC RegionRegional networksLATAM Region
01
Global Leadership
Our U.S. headquarters is our technology hub: foundational IP, proprietary energy
algorithms, and zero-to-one innovation, with global patent strategy led from the
United States.
02
Regional Collaboration
We work with scientific and clinical networks across China, Japan, South Korea, and
Brazil — tailoring energy parameters and protocols to regional skin phenotypes and
regulatory standards.
03
Local Delivery
Through our long-term strategic partnership with
Peninsula Medical Group,
we translate engineering into precision manufacturing and scaled delivery, and support each
market with local service and training.
Our Vision
Building world-class products to empower clinics with accessible
growth systems.
Our Core Values
Equality | Innovation | Empathy | Fidelity
Leadership
Honoring the Legacy, Leading the Change
Brandon NyeCEO, Boston Aesthetics
I joined Boston Aesthetics because this industry is ready for a different
answer.
The generation before us built energy-based aesthetics from nothing. Every
practice in this field stands on that work. What they never got the chance to solve were the
things that cost patients and practices the most — the discomfort, the capital cost, and how
quickly a device relationship ends.
For decades, practices have had to choose. Strong results, or a treatment
patients can tolerate. Leading technology, or a capital cost the business can absorb. Those
were never laws of nature. They were problems no one had been rewarded for solving.
So we start where care actually happens — with what physicians see in the room
and what patients feel on the table — and work backward into the device.
Our team has spent decades building the technology this industry runs on. We
honor that legacy by changing what comes next.
Ryan KeithRegional Sales Director, SoutheastLinkedIn
Yingying Huang, MD, PhDCo-founder and Head of Medical Affairs
Research Fellow, Wellman Center for Photomedicine, Massachusetts General Hospital. Instructor, Harvard Medical School.
LinkedIn
By 2032
Where we are going.
30,000Provider accounts
50 millionPatients served
$1.5 billionAnnual sales
By 2032, our goal is to reach 30,000 provider accounts, serve
50 million patients, and achieve $1.5 billion in annual sales.
These are goals, not projections or guarantees of future
performance.
The portfolio
How we get there.
Two platforms in market, one about to be unveiled, and three more in development. That roadmap is what the numbers above are built on.
Specifications and clinical data follow once each platform clears development.
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
